trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Eczema is primarily caused by skin barrier dysfunction and immune dysregulation

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Current dermatological evidence consistently supports the consensus that eczema (atopic dermatitis) is fundamentally driven by a combination of epidermal barrier dysfunction and immune dysregulation.

The analysis

The retrieved literature consistently emphasizes that atopic dermatitis is driven by an interactive axis of epidermal barrier defects and immune dysregulation, such as Type 2 inflammation. Multiple reviews confirm these are the core components of the disease's etiopathogenesis.

Evidence for · 4
Hypothesis: from epidermal barrier dysfunction to atopic disorders
Recorded source metadata

Alain Taïeb. Hypothesis: from epidermal barrier dysfunction to atopic disorders. 1999. https://doi.org/10.1111/j.1600-0536.1999.tb06125.x

Proposes that an impaired epidermal barrier is a primary underlying cause of atopic disorders.

See more details
More for · 3
The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update
Recorded source metadata

Tubanur Çetinarslan, Lisa Kümper, Regina Fölster-Holst. The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update. 2023. https://doi.org/10.3389/fmolb.2023.1159404

Highlights structural and immunological epidermal barrier defects alongside immune pathway activation as core factors in atopic dermatitis pathophysiology.

The Therapeutic Potential of Polyphenols in Modulating Barrier Lipids, Microbiome Interactions, and Inflammatory Pathways in Atopic Dermatitis.
Recorded source metadata

Blady K, Pomianowski B, Smółka L, Strugała M, Kursa K, Stanek A. The Therapeutic Potential of Polyphenols in Modulating Barrier Lipids, Microbiome Interactions, and Inflammatory Pathways in Atopic Dermatitis.. 2026. https://doi.org/10.3390/nu18091365

Identifies epidermal barrier dysfunction and immune dysregulation as central components of atopic dermatitis pathogenesis.

IL-4/IL-13-Driven Dysregulation of Epidermal Lipid Metabolism in Atopic Dermatitis: An Immunometabolic Link Between Type 2 Inflammation and Barrier Dysfunction.
Recorded source metadata

Andrzejczak K, Sternak A, Witkowski W, Flak A, Maj J, Ponikowska M. IL-4/IL-13-Driven Dysregulation of Epidermal Lipid Metabolism in Atopic Dermatitis: An Immunometabolic Link Between Type 2 Inflammation and Barrier Dysfunction.. 2026. https://doi.org/10.3390/cells15121130

Details how type 2 immune dysregulation directly drives epidermal lipid metabolism defects, linking inflammation and barrier dysfunction.

The paper trail · every fact has a biography
first checked01 Aug 2026
judged → SUPPORTED · 8801 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt